Berlin, 21.09.2021 (GA2LEN UCARE Network). Burning, itching, pain - more than one percent of the world’s population suffers from chronic urticaria (hives) and the number is growing. Unfortunately, this disease still receives too little public attention. The GA²LEN UCARE Network, the Urticaria Network (UNEV) and the German Allergy and Asthma Association (DAAB) have therefore been initiating World...

Professor Maurer discusses chronic urticaria with Sarah Lepsy who runs multiple groups for patients with urticaria and has a message for patients that are feeling hopeless.

In this episode, our host is joined by Dr Ivan Chérrez Ojeda, an urticariologist and communication technology enthusiast, to discuss the potential application of telemedicine in the management of patients with chronic urticaria.

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

Could targeting cytokines produced by autoreactive T cells benefit patients with chronic spontaneous urticaria (CSU)? Professor Marcus Maurer is joined by Professor Elias Toubi to discuss the role of T cells in CSU.

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

At EAACI 2021 touchIMMUNOLOGY has joined Professor Marcus Maurer (Charité – Universitätsmedizin Berlin, Berlin, Germany) to discuss the rationale behind avapritinib for advanced systemic mastocytosis and the results of the PATHFINDER study.

At EAACI 2021 touchIMMUNOLOGY were delighted to talk with Professor Marcus Maurer (Charité – Universitätsmedizin Berlin, Berlin, Germany) to discuss the Phase 1a study of CDX-0159 in patients with chronic inducible urticaria.

The overall aim of this webinar is to improve the management and awareness of solar urticaria and its differential diagnoses by learning about the clinical spectrum of UV-light induced skin diseases

In this episode, Dr Young-Min Ye shares the findings of her cutting-edge research into predictors of remission in chronic urticaria, and explains what is currently known about the role of Mas-related G protein coupled receptor X2 (MRGPRX2) in the activation of mast cells.

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

How do comorbidities affect patients with chronic spontaneous urticaria and what can be done to minimise their impact? Find out more on this crucial, yet understudied topic from our latest guest, Dr Simon Francis Thomsen.

www.medthority.com/csu-learning-zone/podcast-series/

In this episode, our host is joined by Dr Moshe Ben-Shoshan, who shares his pioneering approach to treating paediatric patients and draws on his experience to debunk some of the common myths surrounding childhood urticaria.

https://www.medthority.com/csu-learning-zone/podcast-series/